"yes" to "Have you ever been told by a doctor or other health professional that you have some form of arthritis, rheumatoid arthritis, gout, lupus, or fibromyalgia?" Those who responded "yes" to having doctor-diagnosed arthritis were asked "Are you limited in any way in any of your usual activities because of arthritis or joint symptoms?" Those responding "yes" to both questions were categorized as having AAAL.
Statistical software was used to account for complex multistage sampling design and produce weighted estimates and 95% confidence intervals. Unadjusted prevalence was estimated to describe the actual population burden; age-adjusted Arthritis is a large and growing public health problem in the United States (1) , resulting in costs of $128 billion annually, and continues to be the most common cause of disability (2) . With the aging of the U.S. population, even assuming that the prevalence of obesity and other risk factors remain unchanged, the prevalence of doctor-diagnosed arthritis and arthritisattributable activity limitation (AAAL) is expected to increase significantly by 2030 (1) . To update previous U.S. estimates of doctor-diagnosed arthritis and AAAL, CDC analyzed National Health Interview Survey (NHIS) data from [2007] [2008] [2009] . This report summarizes the results of that analysis, which found that 22.2% (49.9 million) of adults aged ≥18 years had selfreported doctor-diagnosed arthritis, and 9.4% (21.1 million or 42.4% of those with arthritis) had AAAL. Among persons who are obese, an age-adjusted 33.8% of women and 25.2% of men reported doctor-diagnosed arthritis. Arthritis and AAAL represent a major public health problem in the United States that can be addressed, at least in part, by implementing proven obesity prevention strategies and increasing availability of effective physical activity programs and self-management education courses in local communities.
NHIS is an annual, in-person interview survey of the health status and behaviors of the noninstitutionalized U.S. population of all ages. The analysis described in this report used the sample adult component, which is limited to persons aged ≥18 years. One adult per selected household was chosen randomly to participate. Because NHIS oversamples blacks, Hispanics, and Asians, persons in these populations aged ≥65 years have twice the probability of being selected, compared with other adults. For this analysis, NHIS data from 2007, 2008 , and 2009 were combined, and annualized prevalence estimates were calculated and stratified by selected characteristics (i.e., sex, age group, race/ ethnicity, education level, body mass index (BMI) category,* prevalence, standardized to the 2000 U.S. standard population, was estimated to facilitate comparisons among demographic subgroups. For all comparisons, statistical significance was determined using a twosided t-test; differences were considered statistically significant at p<0.05.
During 2007-2009, an estimated 22.2% (49.9 million) of U.S. adults reported doctor-diagnosed arthritis. Arthritis prevalence increased significantly with age. After adjustment for age, arthritis prevalence was significantly higher among women (24.3%) than among men (18.2%); those with less than a high school diploma (21.9%), compared with those with at least some college (20.5%); persons who are obese (29.6%), compared with normal/underweight (16.9%) and overweight (19.8% ); physically inactive persons (23.5%) versus those meeting physical activity recommendations (18.7%); and current (23.7%) or former (25.4%) smokers, compared with never smokers (19.0%) (Table) . For all these comparisons, p values were <0.001.
During [2007] [2008] [2009] , an estimated 9.4% (21.1 million) of U.S. adults reported AAAL. After adjustment for age, patterns of prevalence of AAAL were similar to those for doctor-diagnosed arthritis (Table) .
Among adults reporting doctor-diagnosed arthritis, the unadjusted prevalence of AAAL was 42.4%. After adjustment for age, the greatest prevalences were among persons categorized as obese class III (52.9%), those with less than a high school diploma (52.0%), physically inactive persons (51.2%), current smokers (47.6%), those categorized as obese class II (46.7%), and non-Hispanic blacks (45.5%) (Table) .
Among both men and women, age-adjusted arthritis prevalence increased significantly with increasing BMI (p<0.001 for trend). The age-adjusted prevalence among persons who are obese (25.2% for men, 33.8% for women) was approximately double that for persons who are underweight/normal weight (13.8% for men, 18.9% for women) (Figure) . Among those with arthritis, the age-adjusted prevalence of AAAL also increased significantly with increasing BMI, from 34.7% for those who are underweight/normal weight to 44.8% for those who are obese (Table) .
Age group (yrs)
18-44 7.6 (7. Obesity is associated with onset of knee osteoarthritis (the most common type of arthritis), disease progression, disability, total knee joint replacement, and poor clinical outcomes after knee joint replacement, and likely has a critical role in the increasing impact of arthritis on disability, health-related quality of life, and health-care costs (5) . Lifetime risk for symptomatic knee osteoarthritis alone is 60.5% among persons who are obese, double the risk for those of normal/ underweight (6) . Because even small amounts of weight loss (approximately 11 lbs [5 kg]) can reduce the risk for incident knee osteoarthritis among women by 50% (7) and might also reduce mortality risk in osteoarthritis patients by half (8) , large-scale clinical and community efforts to prevent and treat obesity as recommended by the National Institutes of Health ¶ might reduce the obesity-related burden and impact of arthritis in the population.
The findings in this report are subject to at least four limitations. First, doctor-diagnosed arthritis was self-reported and not confirmed by a health-care professional; however, self-reports are sufficiently sensitive for public health surveillance (9) . Second, osteoarthritis, rheumatoid arthritis, gout, lupus, and fibromyalgia have different etiologies and risk factors; however, the public health recommendations for these different types of arthritis are the same (e.g., weight loss and increased physical activity), regardless of differences in etiology or medical management. Third, because NHIS is a cross-sectional survey, a cause-effect relationship between risk factors (e.g., obesity) and arthritis and AAAL could not be determined; certain risk factors, such as obesity, could develop after onset of arthritis. However, prospective studies consistently have identified excess body weight as a risk factor for incident arthritis, particularly lower extremity osteoarthritis (5, 7) . Finally, because all NHIS information is selfreported, underreporting of weight and overreporting of leisure-time physical activity might have occurred because of social desirability bias. ¶ Available at http://www.nhlbi.nih.gov/guidelines/obesity/ob_gdlns.htm.
What is already known on this topic?
Arthritis is a large and growing public health problem in the United States, resulting in costs of $128 billion annually, and continues to be the most common cause of disability.
What does this report add?
During 2007-2009, 22.2% of adults aged ≥18 years (49.9 million) had self-reported doctor-diagnosed arthritis, and 9.4% (21.1 million or 42.4% of those with arthritis) had self-reported arthritis-attributable activity limitation (AAAL). Among persons who are obese, an age-adjusted 33.8% of women and 25.2% of men reported doctor-diagnosed arthritis.
What are the implications for public health?
Arthritis and AAAL represent a major public health problem in the United States that can be addressed, at least in part, by implementing proven obesity prevention strategies and increasing availability of effective physical activity programs and self-management education courses in local communities.
Both clinical treatment guidelines (10) and public health recommendations for osteoarthritis** call for proven community-based intervention strategies (e.g., self-management education, increased physical activity, and weight management) to reduce pain and improve physical function and health-related qualityof-life for persons with osteoarthritis. Health-care providers and public health organizations should work together to increase the availability of these interventions for persons with all types of arthritis.
Annual influenza vaccination was first recommended for children aged 6- An IIS is a confidential, computerized information system that collects and consolidates vaccination data from multiple health-care providers, generates reminder and recall notifications, and assesses vaccination coverage within a defined geographic area. For the 2008-2012 IIS sentinel site project period, CDC awarded supplemental funds to eight IIS sites to enhance data quality at the sites and to analyze data routinely to monitor immunization practices and vaccination coverage among children aged <19 years in the sentinel site geographic regions. The eight sites meet the following data quality criteria: 1) >85% of child vaccine provider sites were enrolled in IIS, 2) >85% of children aged <19 years who resided in the sentinel site region had ≥2 vaccine doses of any type recorded in IIS, and 3) >70% of administered doses were reported to IIS within 30 days of vaccination. IIS sentinel site results are not intended to be representative of and generalizable to vaccination practices in the United States; however, sentinel site data are complementary to other sources of influenza vaccination coverage (e.g., National Immunization Survey [NIS] and National H1N1 Flu Survey [NHFS]) because data 1) are provider-verified, 2) can track vaccination patterns throughout the entire influenza vaccination season, 3) can assess fully vaccinated status of children, and 4) can monitor vaccination among children and adolescents longitudinally. The six sentinel site areas in Arizona, Colorado, Michigan, Minnesota, Oregon, and Wisconsin consist of subsets of the entire state; the other two sentinel sites consist of the entire state of North Dakota and all of New York City.
To reflect ACIP recommendations for the 2009-10 influenza season (4), full vaccination with seasonal influenza vaccine for children aged 6 months-8 years was defined as 1) receipt of 2 valid vaccine doses (i.e., separated by at least 4 weeks) in the current season among previously unvaccinated children, 2) receipt of 2 valid doses among children who received only 1 dose for the first time during August 1, 2008-March 31, 2009, or 3) receipt of 1 vaccine dose in the current season among all other children. Children aged 9-18 years were considered fully vaccinated with receipt of 1 vaccine dose. Vaccination coverage was calculated for children aged 6-23 months, 2-4 years, 5-12 years, and 13-18 years who resided in a sentinel site area during the 2009-10 influenza season. Analyses included only children who were in the specified age groups during the entire influenza season to ensure that all children evaluated had the same opportunity for vaccination; children who aged into or out of an age group during the season were excluded because they would have had less time within the period to be vaccinated as part of the specified age group. As of March 31, 2010, a total of 5,361,835 children aged 6 months-18 years had been evaluated for this investigation (range: 37,061 in Colorado to 2, 518, 553 
Editorial Note
The data in this report underscore the minimal increase in vaccination coverage among children aged 6-23 months from the 2008-09 season to the 2009-10 season, the continued low coverage among older children despite larger increases observed in these age groups, and the low full vaccination coverage among young children, leaving many unprotected against influenza. Several factors likely affected seasonal influenza vaccination coverage in the 2009-10 season, including new ACIP recommendations for vaccination of children aged 5-18 years, the presence of two separate influenza vaccines (for seasonal influenza and for 2009 influenza A (H1N1) and vaccination recommendations for each, and increased demand for seasonal influenza vaccine early in the season that strained vaccine supplies. However, the individual effect of each of these contributing factors on seasonal influenza vaccination coverage during the 2009-10 season is unknown.
Seasonal influenza vaccination recommendations have been in place for children aged 6-23 months for six seasons and for children aged 2-4 years for four seasons. For the first seasons, ACIP recommendations were issued for routine influenza vaccination of children aged 6-23 months and 2-4 years; coverage with ≥1 doses in these age groups reached approximately 30% (6,7) and 20% (8), respectively. Although vaccine providers were encouraged to implement the ACIP recommendation to vaccinate routinely children aged 5-18 years during the 2008-09 season, 2009-10 was the first season the ACIP recommendation was expected to be implemented fully, and coverage with ≥1 doses was similar to early coverage among younger children (3, 4 seasonal influenza vaccine during the 2009-10 season. The low vaccination coverage among children aged 13-18 years, which might reflect fewer visits to primary-care providers in this age group, might be improved by SLV programs for these children.
Data from the NHFS and the Behavioral Risk Factor Surveillance System (BRFSS) were combined to report national and state-specific seasonal influenza vaccination coverage for the 2009-10 season among children aged 6 months-17 years (9) . State-specific coverage was approximately 14 percentage points higher in the NHFS/BRFSS data compared with sentinel site data. Differences in coverage might reflect differences in geographic assessment areas in six of the eight sites, overreporting in the surveys, underreporting in IIS, or a combination of these factors. NHFS and BRFSS rely on self-report of vaccination and have been found to overestimate the number of seasonal influenza vaccine doses administered in the United States and to overestimate coverage by 10%-15% (9) The data in this report demonstrate the increase in seasonal influenza vaccination coverage among children in the eight sentinel sites during the 2009-10 influenza season. The lack of increased vaccination coverage among children aged 6-23 months, low full vaccination coverage among children aged <5 years who are at greatest risk for influenza-associated complications, What are the implications for public health practice?
The development of new strategies and the continued implementation of proven existing strategies to improve seasonal vaccination coverage are needed, including vaccinating later in the season (JanuaryMarch), standing orders, reminder/recall notifications, parental education about vaccination, and use of school-located vaccination programs. Influenza vaccinations administered in all settings should be reported to facilitate timely monitoring of vaccination coverage among children.
From June 13 to September 25, 2010, the United States experienced low levels of influenza activity. During this period, typical seasonal patterns of influenza activity occurred in the Southern Hemisphere; in addition, influenza activity was observed in the tropical regions, with a mix of 2009 influenza A (H1N1), influenza A (H3N2), and influenza B viruses cocirculating. This report summarizes influenza activity in the United States and worldwide since the update published on July 30, 2010 (1).
United States
In the United States, CDC collaborates with federal, state, and local partners to collect influenza information via multiple surveillance systems. During the summer period of June 13-September 25, 2010, influenza surveillance systems that were in operation included: 1) World Health Organization (WHO) and National Respiratory and Enteric Virus Surveillance System (NREVSS) collaborating laboratories, which conduct viral surveillance; 2) the U.S. Outpatient Influenza-Like Illness Surveillance Network (ILINet), which reports outpatient visits for influenza-like illness (ILI)*; 3) the BioSense Program, which contains chief complaint and discharge diagnosis data on emergency department visits due to ILI; 4) pneumonia and influenza deaths from the 122 Cities Mortality Reporting System; 5) influenza-associated pediatric deaths from the Influenza-Associated Pediatric Mortality Reporting System; and 6) reports of novel influenza A virus cases from the National Notifiable Disease Surveillance System (NNDSS).
During June 13-September 25, WHO and NREVSS collaborating laboratories analyzed a total of 25,833 respiratory specimens from the United States. Of these specimens, 326 (1.3%) tested positive for influenza; 261 (80%) were influenza A viruses, and 65 (20%) were influenza B viruses. Of the influenza A viruses, 185 (71%) were subtyped; 130 (70%) were H3, and 55 (30%) were 2009 influenza A (H1N1). The percentage of specimens positive for influenza varied slightly over time, with <1% of tested specimens positive each week until late July and 1.0%-2.6% of tested specimens positive from late July through late September. The largest proportion of positive samples came from the southeastern United States (U.S. Department of Health and Human Services Region 4: Alabama, Florida, Georgia, Kentucky, Mississippi, North Carolina, South Carolina, and Tennessee) (40%), followed by western states (Region 9: Arizona, California, Hawaii, and Nevada) (14%), and the Midwestern states (Region 5: Illinois, Indiana, Missouri, Minnesota, Ohio, and Wisconsin) (10%).
The weekly percentage of outpatient visits to ILINet providers for ILI during June 13-September 25 ranged from 0.7% to 1%, which is below the national baseline † of 2.3%. This was consistent with data provided by the BioSense Program, which indicated a low level of ILI visits in emergency departments (0.7%-1.7%). Mortality attributed to pneumonia and influenza, as reported by the 122 Cities Mortality Reporting System, was below the epidemic threshold § throughout the period covered by this report except for 3 nonconsecutive weeks. No influenza-associated pediatric deaths were reported to the InfluenzaAssociated Pediatric Mortality Reporting System, and no human cases of novel influenza A were reported to NNDSS for the period June 13-September 25.
In early July, two outbreaks of influenza A (H3) were reported in Iowa. The first outbreak caused ILI in four of 13 members of a college sports team; three of these four were found to be positive for influenza A by rapid test, and two of three were later confirmed to have influenza A (H3) infection by polymerase chain reaction (PCR). The second outbreak involved nine of 12 children and one parent with ILI in a child care setting; two children were rapid-test positive for Influenza Activity -United States and Worldwide, June 13-September 25, 2010
* Defined as a temperature of ≥100.0°F (≥37.8°C), oral or equivalent, and cough and/or sore throat, in the absence of a known cause other than influenza. † The national baseline was calculated as the mean percentage of patient visits for ILI during noninfluenza weeks for the preceding three influenza seasons, plus 2 standard deviations. Noninfluenza weeks are those in which <10% of laboratory specimens are positive for influenza. Wide variety in regional data precludes calculating region-specific baselines; therefore, applying the national baseline to regional data is inappropriate. National and regional percentages of patient visits for ILI are weighted on the basis of state population. § The epidemic threshold is 1.645 standard deviations above the seasonal baseline. The seasonal baseline is projected using a robust regression procedure that applies a periodic regression model to the observed percentage of deaths from pneumonia and influenza during the preceding 5 years. influenza A, and one was PCR-positive for influenza A (H3) infection. None of these patients had a direct history of recent travel, and no epidemiologic links were identified between the two Iowa outbreaks. The Maryland Department of Health and Mental Hygiene reported an outbreak of influenza B during the first half of August, which involved children visiting the United States as part of an international exchange program. Approximately 35 of 400 children had ILI, and six sought health care at a local hospital. Influenza B was identified in eight cases.
Worldwide
From June 13 to September 25, influenza A (H3), 2009 influenza A (H1N1), and influenza B were identified worldwide. Seasonal influenza A (H1) viruses were reported only rarely. Reports by the WHO Global Influenza Surveillance Network (2) showed that influenza B was the viral type most commonly identified until early July, when 2009 influenza A (H1N1) became the predominant strain. Since late August, influenza A (H3) has been the viral subtype most commonly identified. The WHO Global Surveillance Network reported that the predominant viral type or subtype identified from Asia (44% of analyzed specimens) was H3, followed by 2009 influenza A (H1N1) (32% of specimens) and influenza B (13%), but this varied by country. In Africa, influenza B (44%) viruses were the most common, followed by influenza A (H3) (31%). In South America, 2009 influenza A (H1N1) (32% of specimens) and influenza B (32%) predominated. In North America, 69% of isolates were identified as influenza A (H3) viruses. The 2009 influenza A (H1N1) virus predominated in Oceania (63% of specimens). In Europe a small number of cases were reported, and most specimens (59%) were influenza B, followed by 2009 influenza A (H1N1) (19%).
Antigenic Characterization of Influenza Virus Isolates
Virus isolates from around the world are received and analyzed at the WHO Collaborating Center for Surveillance, Epidemiology, and Control of Influenza, located at CDC. Seventy-nine 2009 influenza A (H1N1) viruses were collected and analyzed from June 13 to September 25 (16 from the United States, 33 from South America, 13 from Asia, 15 from Africa, and two from Oceania); all but one (99%) were 
Resistance Profiles of Influenza Virus Isolates
The WHO Collaborating Center for Surveillance, Epidemiology, and Control of Influenza at CDC tested isolates collected during June 13-September 25, 2010, for resistance to antiviral medications. Of 232 isolates tested for neuraminidase inhibitor resistance, 178 were received from 18 foreign countries (52 were 2009 influenza A [H1N1], 85 were H3N2, and 41 were influenza B), and 54 were collected from the United States (17 were 2009 influenza A [H1N1], 25 were H3N2, and 12 were influenza B). None of the 232 tested viruses were found to be resistant to either oseltamivir or zanamivir. Of 180 isolates tested for adamantane resistance (139 foreign isolates and 41 isolates from the United States), 100% were found to be resistant to adamantanes.
Human Infection with Avian Influenza A (H5N1) Virus Isolates
During June 13-September 25, six cases of human infection with avian influenza A (H5N1) were reported to WHO from Egypt and Indonesia; five of these cases were fatal (3 Although it is difficult to predict which influenza virus strains will predominate during the upcoming influenza season, antigenic characterization of viral isolates submitted during the summer demonstrated that the majority are antigenically similar to the influenza vaccine candidates included in the 2010-11 Northern Hemisphere vaccine. Vaccination continues to be the best method for preventing influenza and its associated complications. Vaccine manufacturers project ample supplies of influenza vaccine in the United States for the 2010-11 influenza season. Guidelines for influenza vaccination, published in July 2010, were revised this year by the Advisory Committee on Immunization Practices (ACIP) and call for annual vaccination of all persons aged ≥6 months (4) . Because children aged <6 months are too young for influenza vaccination but are one of the groups at highest risk for influenza-related hospitalization, vaccination of household contacts and caregivers of young children is recommended to reduce their risk for influenza illness (4). Vaccination of pregnant women might also provide protection to infants aged <6 months in addition to protecting women during pregnancy and the postpartum period (5,6).
On August 5, 2010, ACIP recommended that trivalent inactivated influenza vaccine (brand name Afluria) manufactured by CSL Biotherapies, not be administered to children aged 6 months-8 years (7). This recommendation was based on findings of an increased risk for fever in children aged <9 years and febrile seizures among children aged <5 years in Australia and New Zealand associated with receipt of CSL Southern Hemisphere trivalent inactivated vaccine (TIV). If no other age-appropriate, licensed seasonal influenza vaccine is available for a child aged 5-8 years who has a medical condition that increases their risk for influenza complications, Afluria may be given, and providers should discuss the benefits and risks of influenza vaccination with the parents or caregivers before administering Afluria (7) . No cause has been identified to date to explain these adverse reactions in children who received CSL TIV. Safety of seasonal influenza vaccine will continue to be monitored through the season.
Antiviral medications for treatment and prevention of influenza continue to be an important adjunct to vaccination as part of efforts to reduce serious morbidity and mortality related to influenza (8) . Because all H3N2 and 2009 influenza A (H1N1) viruses submitted for testing are resistant to adamantanes (amantadine and rimantidine), adamantane use is not recommended. However, influenza B, influenza A (H3N2), and 2009 influenza A (H1N1) viruses remain susceptible to neuraminidase inhibitors (oseltamivir and zanamivir), and these drugs are recommended agents for influenza prophylaxis and treatment when indicated.
Additional information on influenza testing, use of antiviral medications, influenza infection control guidelines, and vaccination recommendations are available online from CDC at http://www.cdc.gov/ flu. Beginning October 15, 2010, weekly influenza surveillance reports also will be available online at http://www.cdc.gov/flu/weekly. Methods: CDC analyzed data from the 2009 Behavioral Risk Factor Surveillance System (BRFSS) on the prevalence of binge drinking (defined as consuming four or more alcoholic drinks per occasion for women and five or more for men during the past 30 days) among U.S. adults aged ≥18 years who responded to the BRFSS survey by landline or cellular telephone. Data also were analyzed from the 2009 National Youth Risk Behavior Survey (YRBS) on the prevalence of current alcohol use (consuming at least one alcoholic drink during the 30 days before the survey), and binge drinking (consuming five or more alcoholic drinks within a couple of hours during the 30 days before the survey) among U.S. high school students, and on the prevalence of binge drinking among high school students who reported current alcohol use.
Results: Among U.S. adults, the prevalence of reported binge drinking was 15.2% among landline respondents. Binge drinking was more common among men (20.7%), persons aged 18-24 years (25.6%) and 25−34 years (22.5%), whites (16.0%), and persons with annual household incomes of $75,000 or more (19.3%). Among cellular telephone respondents, the overall prevalence of binge drinking (20.6%) was higher than among landline respondents, although the demographic patterns of binge drinking were similar. Prevalence among high school students was 41.8% for current alcohol use, 24.2% for binge drinking, and 60.9% for binge drinking among students who reported current alcohol use.
Conclusions:
Binge drinking is common among U.S. adults, particularly those with higher household incomes, and among high school students. Binge drinking estimates for adults were higher in the cellular telephone sample than in the landline sample. Most youths who reported current alcohol use also reported binge drinking.
Implications for Public Health Practice:
Binge drinking is a serious problem among adults and youths that can be reduced by implementation of evidence-based interventions. 
Methods
BRFSS is a state-based telephone survey of civilian, noninstitutionalized U.S. adults that collects information on many leading health conditions and health risk behaviors, including binge drinking. BRFSS surveys are administered to households with landlines in all states and the District of Columbia (DC)
Respondents who refused to answer, had a missing answer, or who answered "don't know/not sure" were excluded from the analysis.
In 2009, the median Council of American Survey and Research Organizations (CASRO) response rate for the landline BRFSS was 52.9% (range among states: 37.9%-66.9%), and the median CASRO cooperation rate was 75.0% (range: 55.5%-88.0%). The preliminary median CASRO response rate for the cellular telephone BRFSS was 37.6% (range among states: 20.5%-60.3%), and the preliminary median CASRO cooperation rate was 76.0% (range: 47.7%-90.9%). A total of 412,005 landline respondents and 15,578 cellular telephone respondents were included in the analysis. Data collected by landline were weighted to the age, sex, and racial/ethnic distribution of each state's adult population and to the respondent's probability of selection. Cellular telephone data were unweighted, but were age-adjusted to the 2000 U.S. Census standard population.
The biennial national YRBS, a component of CDC's Youth Risk Behavior Surveillance System, estimates the prevalence of health risk behaviors among U.S. high school students. The 2009 national survey obtained cross-sectional data representative of public-and private-school students in grades 9-12 in the 50 states and DC (3). Students completed an anonymous, self-administered questionnaire that included questions about alcohol use. Students from 158 schools completed 16,460 questionnaires. The school response rate was 81%, the student response rate was 88%, and the overall response rate was 71%. After quality control measures were applied, data from 16,410 students were available for analysis.
Current alcohol use is defined in YRBS as having had at least one drink of alcohol on at least 1 day during the 30 days before the survey, and binge drinking is defined as having had five or more drinks of alcohol within a couple of hours on at least 1 day during the 30 days before the survey. The prevalence of current alcohol use was calculated by dividing the total number of respondents who reported current alcohol use by the total number of respondents, and the prevalence of binge drinking was calculated by dividing the total number of respondents who reported binge drinking by the total number of respondents. The prevalence of binge drinking among current drinkers was calculated by dividing the total number of binge drinkers by the total number of current drinkers. Respondents who had missing information were excluded from the analysis. YRBS data were weighted to adjust for school and student nonresponse and oversampling of black and Hispanic students.
BRFSS Results
Landline telephone respondents. The overall prevalence of binge drinking among adult BRFSS landline respondents was 15.2% (Table 1) . Binge drinking prevalence among men (20.7%) was twice that for women (10.0%). Binge drinking also was most common among persons aged 18-24 years (25.6%) and 25-34 years (22.5%), and then gradually declined with increasing age. The prevalence of binge drinking among landline respondents who were non-Hispanic whites (16.0%) and Hispanics (16.3%) was significantly higher than the prevalence for non-Hispanic blacks (10.3%). Landline respondents with some college education (16.4%) and college graduates (15.3%) were most likely to report binge drinking, whereas those who did not graduate from high school were the least likely to report binge drinking (12.1%). Binge drinking prevalence also increased with household income and was most commonly reported by respondents with annual household incomes of $75,000 or more (19.3%).
By state, the prevalence of binge drinking ranged from 6.8% (Tennessee) to 23.9% (Wisconsin) (Figure 1) . States with the highest prevalence of adult binge drinking were located in the Midwest, North Central Plains, and lower New England. Additional high-prevalence states included Alaska, Delaware, DC, and Nevada. Cellular telephone respondents. In 2009, the overall, age-adjusted prevalence of binge drinking among adult BRFSS cellular telephone respondents was 20.6% (Table 2) . Binge drinking prevalence among men (26.5%) was almost twice that for women (14.5%). Binge drinking also was most common among persons aged 18-24 years (35.4%) and 25-34 years (30.8%), and then gradually declined with increasing age. The prevalence of binge drinking among cellular telephone respondents who were non-Hispanic whites (22.3%), other non-Hispanics (including American Indians/Alaska Natives and Asians/Native Hawaiians or other Pacific Islanders) (19.9%), and Hispanics (17.5%) was significantly higher than the prevalence for non-Hispanic blacks (13.9%). Binge drinking prevalence increased with household income and was reported most commonly by respondents with annual household incomes of $75,000 or more (25.4%).
YRBS Results
In 2009, the prevalence of current alcohol use and of binge drinking among high school students was 41.8% and 24.2%, respectively (Table 3 ). The prevalence of binge drinking was similar among boys (25.0%) and girls (23.4%). Non-Hispanic white (27.8%) and Hispanic (24.1%) students had a higher prevalence of reported binge drinking than non-Hispanic black students (13.7%). Binge drinking prevalence increased with grade level; prevalence among 12th grade students (33.5%) was more than twice that among 9th grade students (15.3%).
The prevalence of binge drinking among high school students who reported current alcohol use was 60.9% (64.1% among boys and 57.5% among girls) (Table 3) . Non-Hispanic white (64.8%) and Hispanic (59.3%) students who reported current alcohol use had a higher prevalence of binge drinking than nonHispanic black (43.5%) students who reported current alcohol use. The prevalence of binge drinking among students who reported current alcohol use increased with grade level, from 51.1% in 9th grade students to 67.4% in 12th grade students.
From 1993 to 2009, the prevalence of binge drinking among adults did not decrease among men or women. Among high school students, the prevalence of binge drinking decreased among boys, but has remained about the same among girls (Figure 2 ).
Conclusions and Comment
The results in this report indicate that binge drinking is common among U.S. adults and high school students. Binge drinking among adults was slightly higher in 2009 (15.2%) than in 1993 (14.2%). ¶ Although binge drinking continued to be common among all population groups, it was most common among males, persons aged 18-34 years, and those with annual household incomes of $75,000 or more. Estimates of binge drinking were higher for the cellular telephone sample (20.6% overall) than the landline sample (15.2% overall), particularly among younger adults. By state, compared to 1993, the prevalence of binge drinking among adults in 2009 was significantly greater in 20 states, was significantly less in two states, and stayed about the same in 29 states (CDC, unpublished data, 2010). The prevalence of current alcohol use and binge drinking among high school students ) ; however, the differences in these measures were significant among boys, but not girls.** Current alcohol use and binge drinking increased with grade. The majority of high school students who report current alcohol use also report binge drinking across all demographic groups, except black students. Among adults, 29% of those who report current drinking also report binge drinking (4). The higher prevalence of binge drinking among adult males, whites, young adults, and persons with higher household incomes has been reported before (5) . The high prevalence partly could reflect that binge drinking, unlike other leading health risks (e.g., smoking and obesity), has not been widely recognized as a health risk or subjected to intense prevention efforts (4). The differences in binge drinking among population groups might reflect differences in state and local laws that affect the price, availability, and marketing of alcoholic beverages (6) . Estimates of binge drinking from the cellular telephone sample were higher than from the landline sample, although the demographic patterns of binge drinking were similar. Higher estimates of binge drinking have been reported previously among cellular telephone respondents relative to landline respondents in a small number of states (CDC, unpublished data, 2010), but have not been reported nationally. During the last half of 2009, an estimated 24.5% of U.S. households had only cellular telephones. † † As the U.S. population increasingly adopts cellular telephones in place of landlines, the BRFSS survey will need to incorporate cellular telephone respondents to help assure representativeness, particularly when measuring behaviors that are common among younger adults.
The high prevalence of binge drinking among high school students also is consistent with previous reports (7), and affirms that most youths who drink alcohol do so to the point of intoxication. The similarities in the distribution of binge drinking among youths and adults by various demographic characteristics (e.g., race and ethnicity) also are consistent with the strong relationship between youth and adult drinking in states (8) , which is influenced strongly by state alcohol control policies (6). The findings in this report are subject to at least six limitations. First, BRFSS and YRBS data are self-reported. Among adults, alcohol consumption generally, and excessive drinking in particular, are underreported in surveys because of recall, social desirability, and nonresponse bias (9) . A recent study found that BRFSS identifies only 22% to 32% of presumed alcohol consumption in states based on alcohol sales (10) . Second, an increasing proportion of youths and young adults aged 18-34 years use cellular telephones exclusively (11); therefore, landline surveys of persons in this age group might not be representative of this population. Third, the results of the cellular telephone survey were unweighted, but results of the landline survey were weighted to represent the U.S. adult population. However, the distribution of cellular telephone respondents by various demographic characteristics (e.g., sex and race/ethnicity) was quite similar to the composition of the general population, and the cellular telephone data were age-adjusted to the 2000 U.S. Census standard population. Fourth, response rates for both the landline and cellular telephone BRFSS were low, which increases the risk for response bias. Fifth, YRBS defines binge drinking for boys and girls as five or more drinks within a couple of hours, and the prevalence of binge drinking among girls would likely have been higher if it were defined using a four-drink threshold, consistent with national recommendations. Finally, YRBS data apply only to youths who attend school, and therefore are not representative of all persons in this age group. Nationwide, in 2007, of persons aged 16-17 years, approximately 4% were not enrolled in a high school program and had not completed high school. § § To reduce the adverse impact of binge drinking on individuals and communities, health professionals and community leaders should consider implementing interventions that have been proven in scientific studies to reduce binge drinking among adults and youths. Evidence-based interventions for individuals include those recommended by the U.S. Preventive Services Task Force ¶ ¶ and evidence-based interventions for communities include those recommended in the Guide to Community Preventive Services.*** Local leaders need to carefully consider which of these interventions would be most acceptable, feasible, and effective in their communities; other innovative solutions also might be found for tackling this problem and further research is encouraged to find such solutions. The findings in this report also support the need to improve public health surveillance for binge drinking among adults by increasing the number of cellular telephone respondents to the BRFSS. 
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